MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Regeneron Pharmaceuticals Inc

REGN

#207
Regeneron Pharmaceuticals, Inc. - Common Stock
791.5 0 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
789.85
793.27
Year Range
541.00
846.88
Daily Change
-2.01%
Monthly Change
+13.17%
6 month change
+2.65%
Year Change
+37.14%
Previous Close
807.7 1
Open
790.4 9
Low
789.8 5
High
793.2 7
Volume
262
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. Biotechnology
  5. REGN
Open full chart

Financials

Overview Statement Statistics Dividends Documents
Quarterly Annual
Value 202020212022202320242025 TTM

News

Zacks
SNY REGN AZN
15:45
SNY Stock Trading Above 50- & 200-Day SMAs: Buy, Hold or Sell?
Investor's Business Daily
AMGN AZN REGN SNY
yesterday, 13:57
Amgen, AstraZeneca Score With Tezspire; Can They Take On Dupixent?
Seeking Alpha
GSK MRK BMY REGN GILD
yesterday, 12:08
GSK Stock: Still One Of My Top Healthcare Picks (NYSE:GSK)
TipRanks
CHRW GNRC EME FIX MRNA
2 days ago, 20:02
S&P 500 Top Stock Gainers Today, 8/26/26 - TipRanks.com
Barchart
REGN XBI
2 days ago, 12:01
Regeneron Pharmaceuticals Stock Outlook: Is Wall Street Bullish or Bearish?
Seeking Alpha
REGN MRK AMGN NVS SNY
2026.08.25
Regeneron: Why I Still See Upside After The Rally (NASDAQ:REGN)
Investor's Business Daily
FRO REGN MGA
2026.08.21
Oil Shipper Hits New High; Three Stocks Also Near Pivots
Investor's Business Daily
TVTX ETON KNSA MU REGN
2026.08.21
Three Biotech Stocks Stick Out With Their Stellar Charts
Investor's Business Daily
KNSA REGN ETON NTRA
2026.08.21
Kiniksa's Sales Are Expected To Decline — Why That's All According To Plan
Zacks
REGN SNY
2026.08.20
Regeneron Secures FDA Approval for Rare Genetic Disorder Drug
Benzinga
REGN
2026.08.20
Regeneron Secures FDA Approval For Ultra-Rare Bone Disorder Drug - Regeneron Pharmaceuticals (NASDAQ:REGN
Zacks
OPK REGN PFE
2026.08.19
Is OPK Worth Buying as Valuation Meets Improving Business Trends?

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Store
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stocks
  • Metals
MetaTrader 5
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
MQL5 Channels
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Economic Calendar
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Subscribe to algo trading news
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd